Title: Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes: AWeSoMe Study Group Prospective Trial

Status: Unknown
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, and six months after the connection.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Maximum Age: 21
Healthy Volunteers: f
View:

• Diagnosis of type 1 diabetes Diabetes duration ≥ 6 months Routine attendance at clinic visits Initiation of 780G system usage

Locations
Other Locations
Israel
Sheba Medical Center
RECRUITING
Ramat Gan
Contact Information
Primary
Noah Gruber, MD
noah.gruber@sheba.health.gov.il
+972507181666
Backup
Elinor Mauda, BSc
Elinor.Mauda@sheba.health.gov.il
+972543550783
Time Frame
Start Date: 2023-06-01
Completion Date: 2024-06-01
Participants
Target number of participants: 120
Related Therapeutic Areas
Sponsors
Collaborators: Tel-Aviv Sourasky Medical Center, Assaf-Harofeh Medical Center, Maccabi Healthcare Services, Israel, Wolfson Medical Center
Leads: Sheba Medical Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials